Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Knee Osteoarthritis

Part of paid clinical trials in Irvine, California.

Sponsor
Syntr Health Technologies, Inc.
Study ID
NCT05526898
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Accepted

Interventions

  • SyntrFuge System — DEVICE
    Microsized Adipose Tissue
  • Triamcinolone Injection — DRUG
    Corticosteroid

Study Details

This is an multi-center study with the aim of evaluating the efficacy of adipose tissue processed with the SyntrFuge™ system in Orthopedic Surgery, specifically Knee Osteoarthritis. Patients will be enrolled to the treatment group with adipose tissue processed with the SyntrFuge™ system followed by an injection of autologous microsized adipose tissue in the treatment sites or Standard of Care.

Key Dates

First listed
Sep 2, 2022
Start date
Dec 1, 2027
Status verified
Aug 2026
Primary completion
Dec 31, 2029
Completion
Dec 31, 2030

Study Design

Enrollment
180 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: SyntrFuge System
    Adipose tissue microsized via the SyntrFuge System
  • Other: Standard of Care
    Steroid Injection

Primary Outcome Measure

WOMAC [ Time Frame: 6 months, 12 months, 24 months ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Irvine Site 1IrvineCalifornia92618-
Irvine Site 2IrvineCalifornia92618-

Find similar trials in Irvine, CA

By research site

Related Studies